i-SENS Inc Total Liabilities
i-SENS Inc total liabilities. Based on the latest financial reports, i-SENS Inc (099190) has total liabilities worth ₩234.55 Billion KRW (≈ $158.95 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 099190 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of i-SENS Inc (2012–2025)
Total liabilities of i-SENS Inc from 2012 to 2025. This chart illustrates how i-SENS Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of i-SENS Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
i-SENS Inc Competitors by Total Liabilities
The table below lists competitors of i-SENS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Neighborhood Intelligence, Inc. Common Stock
NASDAQ:NXH
|
USA | $419.06 Million |
|
Reef Casino Trust
AU:RCT
|
Australia | AU$91.42 Million |
|
Nordic Halibut AS
OL:NOHAL
|
Norway | Nkr853.22 Million |
|
Syscom Computer Engineering Co
TW:2453
|
Taiwan | NT$2.44 Billion |
|
Premia S.A.
AT:PREMIA
|
Greece | €457.50 Million |
|
Chunil Express
KO:000650
|
Korea | ₩42.56 Billion |
|
Orogen Royalties Inc
V:OGN
|
Canada | CA$2.01 Million |
|
Hi-Tech Pipes Limited
NSE:HITECH
|
India | Rs-13.33 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down i-SENS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 099190 total assets.
Liquidity & Leverage Metrics
i-SENS Inc Total Liabilities Ratios Explained
i-SENS Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how i-SENS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for i-SENS Inc (2012–2025)
The table below shows the annual total liabilities of i-SENS Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩239.34 Billion ≈ $162.20 Million |
-3.45% |
| 2024-12-31 | ₩247.89 Billion ≈ $167.99 Million |
+26.91% |
| 2023-12-31 | ₩195.32 Billion ≈ $132.37 Million |
+19.27% |
| 2022-12-31 | ₩163.76 Billion ≈ $110.98 Million |
+1.81% |
| 2021-12-31 | ₩160.85 Billion ≈ $109.00 Million |
+83.75% |
| 2020-12-31 | ₩87.54 Billion ≈ $59.32 Million |
+22.46% |
| 2019-12-31 | ₩71.48 Billion ≈ $48.44 Million |
+0.50% |
| 2018-12-31 | ₩71.12 Billion ≈ $48.20 Million |
-0.22% |
| 2017-12-31 | ₩71.28 Billion ≈ $48.31 Million |
+9.00% |
| 2016-12-31 | ₩65.39 Billion ≈ $44.32 Million |
+36.87% |
| 2015-12-31 | ₩47.78 Billion ≈ $32.38 Million |
+6.88% |
| 2014-12-31 | ₩44.70 Billion ≈ $30.29 Million |
+20.50% |
| 2013-12-31 | ₩37.10 Billion ≈ $25.14 Million |
+57.12% |
| 2012-12-31 | ₩23.61 Billion ≈ $16.00 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more